Articles · Amandeep Singh, Ph.D. ·
Artificial Intelligence for Better Antibody Drugs: Ready for Prime Time?
Examining the current state and future potential of AI in antibody drug development.
Artificial Intelligence for Better Antibody Drugs: Ready for Prime Time?
AI is transforming antibody drug development, offering new possibilities for faster and more effective therapeutic development.
Current Applications
Antibody design optimization
Affinity prediction
Manufacturability assessment
Future Prospects
Novel epitope discovery
Multi-specific antibody design
Development process automation
This summary is based on a longer article authored by our team and originally published in Pharmaphorum. We invite you to read the full article there for a more in-depth perspective.
Read the full article on Pharmaphorum